Related topics

Bluebird: 2Q Earnings Snapshot

August 2, 2018

CAMBRIDGE, Mass. (AP) _ Bluebird Bio Inc. (BLUE) on Thursday reported a loss of $146 million in its second quarter.

The Cambridge, Massachusetts-based company said it had a loss of $2.91 per share.

The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $2.30 per share.

The biotechnology company posted revenue of $7.9 million in the period, also missing Street forecasts. Seven analysts surveyed by Zacks expected $10.9 million.

Bluebird shares have fallen 13 percent since the beginning of the year. The stock has risen 74 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLUE at https://www.zacks.com/ap/BLUE

Update hourly